Vyne Therapeutics Inc.

06/15/2026 | Press release | Distributed by Public on 06/15/2026 14:46

Supplemental Prospectus (Form 424B3)

Vyne Therapeutics Inc. published this content on June 15, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 15, 2026 at 20:46 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]